Company intelligence / Profile preview
Geneith Pharmaceuticals
- Ownership
- Private
- Employees
- ~119
- Development stage
- Other
Overview
Geneith Pharmaceuticals has a broad portfolio of registered and commercialized generic medicines in Nigeria. Their products include antimalarials such as Camosunate and Coatal Tablets; antibiotics like Erygen oral suspensions and Pulmocef tablets; analgesics such as Boneflex for arthritis; antifungals/dermatologicals like Ketineal Cream; and others. The company focuses on affordable access to quality pharmaceuticals[1][6].
- Therapeutic areas
- GastroenterologyRheumatologyInfectious Diseases
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Geneith Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Geneith Pharmaceuticals.